A new study has shocking results about market-level rather than model-level impacts of value-based payment.
If you’re not asking the right questions, your healthcare organization could be missing out. Here are five questions every healthcare organization should be asking.
A national payer study from Change Healthcare has 10 need-to-know takeaways about value-based innovation.
A new study investigates whether PET scans can help guide treatment in patients with aggressive non-Hodgkin lymphomas.
A lymphoma expert from the Allegheny Health Network Cancer Institute reveals the status of current and pipeline lymphoma treatments and the three new treatments healthcare executives need to keep on their radar.
Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.
We asked several healthcare executives what they are hearing their colleagues talk about the most. Here’s what they said.
A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.
New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.
FDA’s plan to evaluate gene therapies’ impact on surrogate end points is amping up concerns among payers. Here’s why